ANIK vs MELI · rev $62.2M vs P/E 43, rev $19.01B
Anika Therapeutics Inc (ANIK) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
ANIK currently screens at market cap $161.3M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the ANIK and MELI stock pages for the full models.
Not investment advice.